name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-8953854	Metabolism of RNA	646	478	1.63	15	4.3e-52	5.4e-49	3.69	3.07	4.44
R-HSA-1640170	Cell Cycle	607	454	1.64	14.9	1.2e-51	7.4e-49	3.83	3.17	4.66
R-HSA-69278	Cell Cycle, Mitotic	531	398	1.65	14	1.5e-45	6.1e-43	3.83	3.12	4.71
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	243	204	1.84	12.2	4.1e-36	1.3e-33	6.5	4.59	9.44
R-HSA-72172	mRNA Splicing	191	159	1.83	10.6	1.6e-27	4e-25	6.12	4.16	9.27
R-HSA-392499	Metabolism of proteins	1907	1079	1.24	10.8	3.5e-27	7.2e-25	1.73	1.57	1.92
R-HSA-68886	M Phase	391	281	1.58	10.7	5e-27	8.9e-25	3.19	2.54	4.03
R-HSA-72163	mRNA Splicing - Major Pathway	183	153	1.84	10.4	6.2e-27	9.7e-25	6.28	4.22	9.65
R-HSA-2555396	Mitotic Metaphase and Anaphase	203	163	1.76	10.1	9.8e-25	1.4e-22	5.02	3.52	7.3
R-HSA-68882	Mitotic Anaphase	202	162	1.76	10	1.8e-24	2e-22	4.99	3.5	7.26
R-HSA-69242	S Phase	138	120	1.91	9.84	1.6e-24	2e-22	8.17	4.94	14.3
R-HSA-69620	Cell Cycle Checkpoints	292	215	1.62	9.79	4.3e-23	4.4e-21	3.46	2.64	4.56
R-HSA-453279	Mitotic G1-G1/S phases	143	121	1.86	9.46	1.8e-22	1.7e-20	6.73	4.24	11.2
R-HSA-2467813	Separation of Sister Chromatids	191	151	1.74	9.4	1e-21	8.9e-20	4.64	3.25	6.76
R-HSA-69206	G1/S Transition	124	106	1.88	8.99	1.5e-20	1.3e-18	7.19	4.33	12.6
R-HSA-162906	HIV Infection	184	144	1.72	9	5.2e-20	4e-18	4.42	3.08	6.45
R-HSA-3700989	Transcriptional Regulation by TP53	365	250	1.5	8.98	1.6e-19	1.2e-17	2.69	2.14	3.4
R-HSA-597592	Post-translational protein modification	1353	769	1.25	8.99	1.9e-19	1.3e-17	1.69	1.51	1.9
R-HSA-453274	Mitotic G2-G2/M phases	197	151	1.68	8.86	2.3e-19	1.5e-17	4.03	2.87	5.75
R-HSA-68877	Mitotic Prometaphase	199	152	1.68	8.83	3.2e-19	2e-17	3.97	2.84	5.64
R-HSA-8953897	Cellular responses to external stimuli	493	320	1.43	8.86	5.3e-19	3.2e-17	2.31	1.9	2.8
R-HSA-69275	G2/M Transition	195	149	1.68	8.75	6.9e-19	3.9e-17	3.97	2.83	5.67
R-HSA-69306	DNA Replication	108	92	1.87	8.32	8.9e-18	4.8e-16	7	4.08	12.8
R-HSA-162909	Host Interactions of HIV factors	128	105	1.8	8.35	1.2e-17	6.2e-16	5.57	3.51	9.18
R-HSA-73894	DNA Repair	315	217	1.51	8.46	1.6e-17	7.8e-16	2.73	2.14	3.52
R-HSA-72766	Translation	258	183	1.56	8.3	5.5e-17	2.6e-15	3	2.27	3.99
R-HSA-69239	Synthesis of DNA	99	85	1.89	8.1	5.7e-17	2.6e-15	7.38	4.16	14.1
R-HSA-6807070	PTEN Regulation	140	111	1.74	8.08	1.8e-16	8e-15	4.67	3.07	7.31
R-HSA-69618	Mitotic Spindle Checkpoint	112	93	1.82	8.02	1.9e-16	8.1e-15	5.96	3.6	10.4
R-HSA-5368287	Mitochondrial translation	87	76	1.92	7.87	3.2e-16	1.3e-14	8.39	4.43	17.5
R-HSA-5696398	Nucleotide Excision Repair	111	92	1.82	7.95	3.5e-16	1.4e-14	5.89	3.56	10.2
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	83	73	1.93	7.79	5.5e-16	2.1e-14	8.86	4.55	19.3
R-HSA-5419276	Mitochondrial translation termination	86	75	1.92	7.8	6.3e-16	2.4e-14	8.28	4.37	17.3
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	72	1.93	7.72	1.1e-15	3.9e-14	8.74	4.48	19
R-HSA-2262752	Cellular responses to stress	425	273	1.41	7.92	1.8e-15	6.2e-14	2.22	1.81	2.74
R-HSA-1852241	Organelle biogenesis and maintenance	269	186	1.52	7.89	1.9e-15	6.6e-14	2.75	2.11	3.62
R-HSA-199991	Membrane Trafficking	599	366	1.34	7.9	2.1e-15	7e-14	1.96	1.65	2.33
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	81	71	1.93	7.65	2.1e-15	7e-14	8.61	4.41	18.8
R-HSA-5389840	Mitochondrial translation elongation	84	73	1.91	7.65	2.3e-15	7.3e-14	8.05	4.24	16.9
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	84	73	1.91	7.65	2.3e-15	7.3e-14	8.05	4.24	16.9
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	86	74	1.89	7.58	4.8e-15	1.4e-13	7.48	4.03	15.2
R-HSA-453276	Regulation of mitotic cell cycle	86	74	1.89	7.58	4.8e-15	1.4e-13	7.48	4.03	15.2
R-HSA-5663205	Infectious disease	326	217	1.46	7.76	5.9e-15	1.7e-13	2.45	1.93	3.13
R-HSA-446203	Asparagine N-linked glycosylation	299	201	1.48	7.65	1.3e-14	3.8e-13	2.52	1.96	3.25
R-HSA-141424	Amplification of signal from the kinetochores	96	80	1.83	7.48	1.7e-14	4.5e-13	6.07	3.51	11.1
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	96	80	1.83	7.48	1.7e-14	4.5e-13	6.07	3.51	11.1
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	74	65	1.93	7.34	2.6e-14	7e-13	8.75	4.33	20
R-HSA-5653656	Vesicle-mediated transport	631	378	1.32	7.5	4.9e-14	1.3e-12	1.86	1.57	2.2
R-HSA-68874	M/G1 Transition	85	72	1.86	7.29	6.3e-14	1.6e-12	6.72	3.68	13.2
R-HSA-69002	DNA Replication Pre-Initiation	85	72	1.86	7.29	6.3e-14	1.6e-12	6.72	3.68	13.2
R-HSA-5617833	Cilium Assembly	201	143	1.56	7.37	1e-13	2.5e-12	3.01	2.2	4.17
R-HSA-2980766	Nuclear Envelope Breakdown	51	48	2.07	6.99	1.2e-13	2.9e-12	19.3	6.23	97.2
R-HSA-5663220	RHO GTPases Activate Formins	141	107	1.67	7.29	1.4e-13	3.3e-12	3.83	2.58	5.83
R-HSA-162587	HIV Life Cycle	101	82	1.78	7.23	1.4e-13	3.3e-12	5.24	3.15	9.16
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	80	68	1.87	7.12	2.3e-13	5.1e-12	6.87	3.68	14
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	127	98	1.7	7.21	2.5e-13	5.5e-12	4.11	2.69	6.47
R-HSA-69304	Regulation of DNA replication	76	65	1.88	7.03	4.2e-13	9.2e-12	7.16	3.74	15.1
R-HSA-68867	Assembly of the pre-replicative complex	68	59	1.91	6.85	1.4e-12	3e-11	7.93	3.9	18.2
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	74	63	1.87	6.87	1.5e-12	3.2e-11	6.93	3.62	14.6
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	79	66	1.84	6.81	2.7e-12	5.6e-11	6.15	3.36	12.2
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	76	64	1.85	6.8	2.8e-12	5.6e-11	6.46	3.45	13.2
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	76	64	1.85	6.8	2.8e-12	5.6e-11	6.46	3.45	13.2
R-HSA-69300	Removal of licensing factors from origins	73	62	1.87	6.79	2.8e-12	5.6e-11	6.82	3.56	14.4
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	75	63	1.85	6.72	5.2e-12	1e-10	6.36	3.39	13
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	72	61	1.86	6.7	5.4e-12	1e-10	6.71	3.5	14.2
R-HSA-68949	Orc1 removal from chromatin	71	60	1.86	6.62	1e-11	1.8e-10	6.6	3.43	13.9
R-HSA-69052	Switching of origins to a post-replicative state	71	60	1.86	6.62	1e-11	1.8e-10	6.6	3.43	13.9
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	68	58	1.87	6.61	1e-11	1.8e-10	7.02	3.55	15.4
R-HSA-3371556	Cellular response to heat stress	88	71	1.77	6.65	1.1e-11	2e-10	5.06	2.94	9.18
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	41	39	2.09	6.39	1.1e-11	2e-10	23.5	6.08	201
R-HSA-429914	Deadenylation-dependent mRNA decay	55	49	1.96	6.51	1.3e-11	2.3e-10	9.87	4.22	28.2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	310	199	1.41	6.71	1.5e-11	2.5e-10	2.2	1.73	2.81
R-HSA-72187	mRNA 3'-end processing	58	51	1.93	6.5	1.6e-11	2.7e-10	8.81	3.97	23
R-HSA-1257604	PIP3 activates AKT signaling	254	168	1.45	6.68	1.6e-11	2.8e-10	2.39	1.83	3.14
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	73	61	1.84	6.55	1.8e-11	3e-10	6.15	3.27	12.6
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	67	57	1.87	6.52	1.9e-11	3.1e-10	6.89	3.48	15.2
R-HSA-73856	RNA Polymerase II Transcription Termination	67	57	1.87	6.52	1.9e-11	3.1e-10	6.89	3.48	15.2
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	87	70	1.77	6.57	2e-11	3.2e-10	4.99	2.9	9.06
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	40	38	2.09	6.3	2.3e-11	3.6e-10	22.9	5.92	196
R-HSA-195253	Degradation of beta-catenin by the destruction complex	81	66	1.79	6.53	2.6e-11	4e-10	5.33	3	10.1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	72	60	1.83	6.47	3.4e-11	5.2e-10	6.05	3.22	12.4
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	63	54	1.88	6.43	3.6e-11	5.4e-10	7.25	3.55	16.7
R-HSA-4615885	SUMOylation of DNA replication proteins	43	40	2.04	6.27	4.2e-11	6.2e-10	16.1	5.12	81.3
R-HSA-177243	Interactions of Rev with host cellular proteins	35	34	2.13	6.14	4.4e-11	6.5e-10	40.9	6.87	1650
R-HSA-162599	Late Phase of HIV Life Cycle	88	70	1.75	6.44	5.4e-11	7.9e-10	4.71	2.77	8.42
R-HSA-6784531	tRNA processing in the nucleus	56	49	1.92	6.33	6e-11	8.6e-10	8.46	3.81	22.1
R-HSA-5633007	Regulation of TP53 Activity	160	113	1.55	6.43	8.5e-11	1.2e-09	2.92	2.06	4.21
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	34	33	2.13	6.04	9.4e-11	1.3e-09	39.7	6.65	1610
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	34	33	2.13	6.04	9.4e-11	1.3e-09	39.7	6.65	1610
R-HSA-9006925	Intracellular signaling by second messengers	282	181	1.41	6.38	1.3e-10	1.7e-09	2.19	1.7	2.83
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	67	56	1.84	6.28	1.2e-10	1.7e-09	6.15	3.19	13
R-HSA-72312	rRNA processing	201	136	1.49	6.37	1.3e-10	1.8e-09	2.55	1.88	3.49
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	130	1.5	6.32	1.9e-10	2.5e-09	2.6	1.9	3.59
R-HSA-159227	Transport of the SLBP independent Mature mRNA	33	32	2.13	5.94	2e-10	2.6e-09	38.5	6.43	1560
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	33	32	2.13	5.94	2e-10	2.6e-09	38.5	6.43	1560
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	60	51	1.87	6.16	2.4e-10	3.1e-09	6.85	3.33	15.8
R-HSA-180910	Vpr-mediated nuclear import of PICs	32	31	2.13	5.84	4.3e-10	5.5e-09	37.4	6.22	1510
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	59	50	1.86	6.07	4.5e-10	5.8e-09	6.71	3.26	15.5
R-HSA-5696395	Formation of Incision Complex in GG-NER	43	39	1.99	5.96	5.1e-10	6.5e-09	11.8	4.24	45.3
R-HSA-4570464	SUMOylation of RNA binding proteins	46	41	1.96	5.95	6.5e-10	8.1e-09	9.89	3.91	32.1
R-HSA-69481	G2/M Checkpoints	167	115	1.51	6.11	7e-10	8.7e-09	2.69	1.92	3.82
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	86	67	1.71	6.06	7.4e-10	9.1e-09	4.27	2.53	7.54
R-HSA-5678895	Defective CFTR causes cystic fibrosis	61	51	1.84	5.99	8.2e-10	9.8e-09	6.16	3.09	13.6
R-HSA-191859	snRNP Assembly	52	45	1.9	5.95	8.3e-10	9.8e-09	7.76	3.47	20.4
R-HSA-194441	Metabolism of non-coding RNA	52	45	1.9	5.95	8.3e-10	9.8e-09	7.76	3.47	20.4
R-HSA-72306	tRNA processing	83	65	1.72	6.02	9e-10	1e-08	4.37	2.56	7.84
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	47	1.88	5.96	8.6e-10	1e-08	7.09	3.32	17.4
R-HSA-176033	Interactions of Vpr with host cellular proteins	35	33	2.07	5.8	9.2e-10	1.1e-08	19.9	5.08	171
R-HSA-8878166	Transcriptional regulation by RUNX2	80	63	1.73	5.99	1.1e-09	1.2e-08	4.48	2.59	8.19
R-HSA-168325	Viral Messenger RNA Synthesis	42	38	1.99	5.86	1e-09	1.2e-08	11.5	4.12	44.2
R-HSA-6782135	Dual incision in TC-NER	66	54	1.8	5.94	1.3e-09	1.4e-08	5.44	2.87	11.2
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	60	50	1.83	5.9	1.5e-09	1.7e-08	6.04	3.02	13.4
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	60	50	1.83	5.9	1.5e-09	1.7e-08	6.04	3.02	13.4
R-HSA-983169	Class I MHC mediated antigen processing & presentation	365	222	1.34	5.98	1.6e-09	1.8e-08	1.9	1.53	2.37
R-HSA-8951664	Neddylation	235	152	1.42	5.97	1.7e-09	1.9e-08	2.23	1.69	2.96
R-HSA-1643685	Disease	984	536	1.2	5.94	1.9e-09	2.1e-08	1.49	1.3	1.7
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	30	29	2.12	5.63	2e-09	2.1e-08	34.9	5.78	1420
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	30	29	2.12	5.63	2e-09	2.1e-08	34.9	5.78	1420
R-HSA-5696400	Dual Incision in GG-NER	41	37	1.98	5.76	2.1e-09	2.2e-08	11.2	4	43.1
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	65	53	1.79	5.85	2.3e-09	2.4e-08	5.33	2.81	11
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	59	49	1.82	5.81	2.8e-09	2.9e-08	5.92	2.96	13.1
R-HSA-8939902	Regulation of RUNX2 expression and activity	59	49	1.82	5.81	2.8e-09	2.9e-08	5.92	2.96	13.1
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	121	87	1.58	5.86	3.1e-09	3.1e-08	3.1	2.06	4.77
R-HSA-8854518	AURKA Activation by TPX2	72	57	1.74	5.75	4.7e-09	4.8e-08	4.59	2.56	8.74
R-HSA-2990846	SUMOylation	127	90	1.56	5.77	5.4e-09	5.4e-08	2.95	1.99	4.46
R-HSA-8948751	Regulation of PTEN stability and activity	69	55	1.75	5.72	5.6e-09	5.5e-08	4.75	2.6	9.26
R-HSA-8941858	Regulation of RUNX3 expression and activity	55	46	1.84	5.69	5.5e-09	5.5e-08	6.17	2.98	14.3
R-HSA-180534	Vpu mediated degradation of CD4	52	44	1.86	5.68	5.8e-09	5.6e-08	6.64	3.09	16.3
R-HSA-199977	ER to Golgi Anterograde Transport	155	106	1.5	5.76	6e-09	5.8e-08	2.63	1.85	3.77
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	121	1.46	5.73	7.2e-09	6.9e-08	2.41	1.75	3.35
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	97	72	1.63	5.7	7.5e-09	7.2e-08	3.49	2.18	5.75
R-HSA-1169408	ISG15 antiviral mechanism	71	56	1.73	5.66	8.3e-09	7.7e-08	4.51	2.51	8.6
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	71	56	1.73	5.66	8.3e-09	7.7e-08	4.51	2.51	8.6
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	32	30	2.06	5.49	8.3e-09	7.7e-08	18.1	4.58	156
R-HSA-5610780	Degradation of GLI1 by the proteasome	57	47	1.81	5.62	9.5e-09	8.7e-08	5.67	2.82	12.6
R-HSA-5658442	Regulation of RAS by GAPs	68	54	1.74	5.63	9.9e-09	9.1e-08	4.66	2.55	9.1
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	54	45	1.83	5.59	1e-08	9.3e-08	6.03	2.91	14.1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	51	43	1.85	5.58	1.1e-08	9.6e-08	6.48	3.01	16
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	51	43	1.85	5.58	1.1e-08	9.6e-08	6.48	3.01	16
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	51	43	1.85	5.58	1.1e-08	9.6e-08	6.48	3.01	16
R-HSA-379724	tRNA Aminoacylation	35	32	2.01	5.46	1.3e-08	1.1e-07	12.8	4.01	65.7
R-HSA-5610787	Hedgehog 'off' state	113	81	1.57	5.62	1.3e-08	1.2e-07	3.07	2.01	4.78
R-HSA-8878159	Transcriptional regulation by RUNX3	108	78	1.59	5.6	1.4e-08	1.2e-07	3.15	2.04	4.98
R-HSA-4608870	Asymmetric localization of PCP proteins	62	50	1.77	5.57	1.4e-08	1.2e-07	5.03	2.64	10.4
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	200	130	1.43	5.59	1.7e-08	1.4e-07	2.26	1.67	3.07
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	56	46	1.8	5.52	1.7e-08	1.5e-07	5.55	2.76	12.3
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	56	46	1.8	5.52	1.7e-08	1.5e-07	5.55	2.76	12.3
R-HSA-5663202	Diseases of signal transduction	359	215	1.32	5.57	1.9e-08	1.6e-07	1.83	1.47	2.28
R-HSA-380259	Loss of Nlp from mitotic centrosomes	69	54	1.72	5.48	2.5e-08	2.1e-07	4.35	2.41	8.31
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	69	54	1.72	5.48	2.5e-08	2.1e-07	4.35	2.41	8.31
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	92	68	1.62	5.49	2.6e-08	2.2e-07	3.43	2.12	5.72
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	52	43	1.82	5.4	3.5e-08	2.8e-07	5.76	2.77	13.5
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	52	43	1.82	5.4	3.5e-08	2.8e-07	5.76	2.77	13.5
R-HSA-69610	p53-Independent DNA Damage Response	52	43	1.82	5.4	3.5e-08	2.8e-07	5.76	2.77	13.5
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	52	43	1.82	5.4	3.5e-08	2.8e-07	5.76	2.77	13.5
R-HSA-72165	mRNA Splicing - Minor Pathway	52	43	1.82	5.4	3.5e-08	2.8e-07	5.76	2.77	13.5
R-HSA-69615	G1/S DNA Damage Checkpoints	68	53	1.71	5.39	4.4e-08	3.5e-07	4.27	2.37	8.16
R-HSA-69541	Stabilization of p53	57	46	1.77	5.35	5e-08	3.9e-07	5.04	2.57	10.8
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	78	59	1.66	5.36	5.4e-08	4.2e-07	3.75	2.2	6.67
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	80	60	1.65	5.32	7.1e-08	5.4e-07	3.62	2.15	6.36
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	80	60	1.65	5.32	7.1e-08	5.4e-07	3.62	2.15	6.36
R-HSA-380287	Centrosome maturation	80	60	1.65	5.32	7.1e-08	5.4e-07	3.62	2.15	6.36
R-HSA-168276	NS1 Mediated Effects on Host Pathways	39	34	1.92	5.23	7.1e-08	5.4e-07	8.19	3.18	26.9
R-HSA-73884	Base Excision Repair	39	34	1.92	5.23	7.1e-08	5.4e-07	8.19	3.18	26.9
R-HSA-73933	Resolution of Abasic Sites (AP sites)	39	34	1.92	5.23	7.1e-08	5.4e-07	8.19	3.18	26.9
R-HSA-5358351	Signaling by Hedgehog	148	99	1.47	5.26	1.1e-07	7.9e-07	2.45	1.72	3.53
R-HSA-948021	Transport to the Golgi and subsequent modification	186	120	1.42	5.25	1.1e-07	8.3e-07	2.21	1.62	3.04
R-HSA-8943724	Regulation of PTEN gene transcription	61	48	1.73	5.22	1.1e-07	8.4e-07	4.46	2.37	8.97
R-HSA-2871837	FCERI mediated NF-kB activation	79	59	1.64	5.23	1.2e-07	8.7e-07	3.56	2.11	6.26
R-HSA-674695	RNA Polymerase II Pre-transcription Events	84	62	1.62	5.23	1.2e-07	8.7e-07	3.41	2.06	5.83
R-HSA-1169091	Activation of NF-kappaB in B cells	66	51	1.7	5.2	1.3e-07	9.2e-07	4.1	2.27	7.87
R-HSA-69563	p53-Dependent G1 DNA Damage Response	66	51	1.7	5.2	1.3e-07	9.2e-07	4.1	2.27	7.87
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	66	51	1.7	5.2	1.3e-07	9.2e-07	4.1	2.27	7.87
R-HSA-73776	RNA Polymerase II Promoter Escape	47	39	1.82	5.17	1.3e-07	9.2e-07	5.87	2.7	14.6
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	47	39	1.82	5.17	1.3e-07	9.2e-07	5.87	2.7	14.6
R-HSA-75953	RNA Polymerase II Transcription Initiation	47	39	1.82	5.17	1.3e-07	9.2e-07	5.87	2.7	14.6
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	47	39	1.82	5.17	1.3e-07	9.2e-07	5.87	2.7	14.6
R-HSA-5607764	CLEC7A (Dectin-1) signaling	96	69	1.58	5.21	1.3e-07	9.4e-07	3.09	1.95	5.03
R-HSA-168253	Host Interactions with Influenza Factors	41	35	1.88	5.13	1.4e-07	9.8e-07	7.03	2.92	20.5
R-HSA-5688426	Deubiquitination	295	178	1.33	5.19	1.5e-07	1.1e-06	1.85	1.45	2.37
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	68	52	1.68	5.14	1.8e-07	1.2e-06	3.92	2.2	7.37
R-HSA-379716	Cytosolic tRNA aminoacylation	24	23	2.11	4.96	1.8e-07	1.2e-06	27.7	4.49	1130
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	126	86	1.5	5.16	1.8e-07	1.3e-06	2.6	1.76	3.9
R-HSA-4641258	Degradation of DVL	57	45	1.73	5.08	2.4e-07	1.6e-06	4.52	2.35	9.41
R-HSA-176187	Activation of ATR in response to replication stress	37	32	1.9	5.01	2.6e-07	1.8e-06	7.71	2.98	25.4
R-HSA-180585	Vif-mediated degradation of APOBEC3G	54	43	1.75	5.05	2.8e-07	1.9e-06	4.71	2.39	10.1
R-HSA-5387390	Hh mutants abrogate ligand secretion	59	46	1.71	5.02	3.4e-07	2.3e-06	4.27	2.26	8.62
R-HSA-4086400	PCP/CE pathway	89	64	1.58	5.02	3.7e-07	2.5e-06	3.09	1.92	5.14
R-HSA-5358346	Hedgehog ligand biogenesis	64	49	1.68	5	3.9e-07	2.5e-06	3.94	2.17	7.58
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	30	27	1.98	4.9	4.1e-07	2.7e-06	10.8	3.33	55.7
R-HSA-70171	Glycolysis	61	47	1.69	4.96	4.8e-07	3.1e-06	4.05	2.19	7.97
R-HSA-70326	Glucose metabolism	81	59	1.6	4.96	5.2e-07	3.3e-06	3.24	1.95	5.56
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	66	50	1.66	4.95	5.2e-07	3.3e-06	3.77	2.11	7.1
R-HSA-74160	Gene expression (Transcription)	1335	691	1.14	4.92	5.3e-07	3.4e-06	1.33	1.19	1.5
R-HSA-381119	Unfolded Protein Response (UPR)	93	66	1.56	4.95	5.4e-07	3.5e-06	2.95	1.86	4.82
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	26	24	2.03	4.8	6.3e-07	4e-06	14.4	3.58	126
R-HSA-4641257	Degradation of AXIN	55	43	1.72	4.88	7.3e-07	4.6e-06	4.32	2.23	9.01
R-HSA-5689603	UCH proteinases	97	68	1.54	4.89	7.6e-07	4.8e-06	2.83	1.81	4.55
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	29	26	1.97	4.78	8.2e-07	5.1e-06	10.4	3.19	53.8
R-HSA-8953750	Transcriptional Regulation by E2F6	35	30	1.88	4.78	9.6e-07	6e-06	7.22	2.77	23.9
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	57	44	1.7	4.82	1e-06	6.3e-06	4.08	2.16	8.27
R-HSA-5687128	MAPK6/MAPK4 signaling	89	63	1.56	4.81	1.1e-06	7e-06	2.93	1.82	4.82
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	42	1.71	4.77	1.3e-06	7.7e-06	4.22	2.18	8.81
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	25	23	2.02	4.67	1.3e-06	7.8e-06	13.8	3.41	121
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	51	40	1.72	4.73	1.5e-06	9.3e-06	4.38	2.2	9.48
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	93	65	1.54	4.74	1.6e-06	9.5e-06	2.8	1.77	4.54
R-HSA-194315	Signaling by Rho GTPases	441	249	1.24	4.72	1.6e-06	9.5e-06	1.58	1.3	1.93
R-HSA-165159	mTOR signalling	40	33	1.81	4.71	1.6e-06	9.6e-06	5.67	2.47	15.2
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	21	20	2.09	4.58	1.7e-06	1e-05	24	3.84	992
R-HSA-8856688	Golgi-to-ER retrograde transport	134	88	1.44	4.72	1.8e-06	1.1e-05	2.31	1.6	3.39
R-HSA-5693532	DNA Double-Strand Break Repair	165	105	1.4	4.71	1.8e-06	1.1e-05	2.12	1.53	2.97
R-HSA-170834	Signaling by TGF-beta Receptor Complex	66	49	1.63	4.7	1.9e-06	1.1e-05	3.48	1.96	6.45
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	487	272	1.23	4.69	1.8e-06	1.1e-05	1.55	1.28	1.87
R-HSA-5632684	Hedgehog 'on' state	85	60	1.55	4.66	2.4e-06	1.4e-05	2.9	1.79	4.83
R-HSA-1632852	Macroautophagy	68	50	1.62	4.65	2.4e-06	1.4e-05	3.35	1.92	6.11
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	50	39	1.71	4.62	2.7e-06	1.5e-05	4.27	2.14	9.26
R-HSA-74158	RNA Polymerase III Transcription	36	30	1.83	4.56	3.2e-06	1.9e-05	6.02	2.46	17.7
R-HSA-76046	RNA Polymerase III Transcription Initiation	36	30	1.83	4.56	3.2e-06	1.9e-05	6.02	2.46	17.7
R-HSA-180786	Extension of Telomeres	30	26	1.9	4.53	3.5e-06	2e-05	7.82	2.71	30.8
R-HSA-69231	Cyclin D associated events in G1	44	35	1.75	4.54	3.9e-06	2.2e-05	4.68	2.2	11.1
R-HSA-69236	G1 Phase	44	35	1.75	4.54	3.9e-06	2.2e-05	4.68	2.2	11.1
R-HSA-9020702	Interleukin-1 signaling	102	69	1.49	4.51	4.9e-06	2.7e-05	2.53	1.64	3.96
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	35	29	1.82	4.44	6e-06	3.3e-05	5.81	2.37	17.1
R-HSA-68962	Activation of the pre-replicative complex	32	27	1.85	4.42	6.5e-06	3.6e-05	6.49	2.46	21.6
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	108	72	1.46	4.44	6.9e-06	3.8e-05	2.42	1.59	3.72
R-HSA-71403	Citric acid cycle (TCA cycle)	19	18	2.08	4.31	7.5e-06	4.1e-05	21.6	3.41	897
R-HSA-77595	Processing of Intronless Pre-mRNAs	19	18	2.08	4.31	7.5e-06	4.1e-05	21.6	3.41	897
R-HSA-177929	Signaling by EGFR	40	32	1.76	4.39	8.3e-06	4.5e-05	4.81	2.17	12.1
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	75	53	1.55	4.39	8.7e-06	4.7e-05	2.91	1.73	5.02
R-HSA-2262749	Cellular response to hypoxia	75	53	1.55	4.39	8.7e-06	4.7e-05	2.91	1.73	5.02
R-HSA-73762	RNA Polymerase I Transcription Initiation	45	35	1.71	4.35	9.9e-06	5.3e-05	4.21	2.04	9.55
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	65	47	1.59	4.35	1e-05	5.6e-05	3.15	1.79	5.76
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	31	26	1.84	4.29	1.2e-05	6.5e-05	6.25	2.36	20.9
R-HSA-1538133	G0 and Early G1	25	22	1.93	4.27	1.2e-05	6.5e-05	8.81	2.65	46
R-HSA-5685942	HDR through Homologous Recombination (HRR)	67	48	1.57	4.31	1.3e-05	6.7e-05	3.04	1.75	5.49
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	28	24	1.88	4.28	1.3e-05	6.7e-05	7.21	2.48	28.6
R-HSA-4551638	SUMOylation of chromatin organization proteins	69	49	1.56	4.27	1.5e-05	8e-05	2.95	1.72	5.25
R-HSA-3858494	Beta-catenin independent WNT signaling	137	87	1.4	4.26	1.5e-05	8e-05	2.1	1.47	3.05
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	18	17	2.07	4.17	1.6e-05	8.1e-05	20.4	3.2	850
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	49	37	1.66	4.23	1.8e-05	9.5e-05	3.71	1.89	7.83
R-HSA-113418	Formation of the Early Elongation Complex	33	27	1.8	4.19	2e-05	1e-04	5.41	2.19	16
R-HSA-5620920	Cargo trafficking to the periciliary membrane	51	38	1.64	4.17	2.4e-05	0.00012	3.52	1.83	7.21
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	24	21	1.92	4.13	2.4e-05	0.00012	8.41	2.51	44.1
R-HSA-69190	DNA strand elongation	24	21	1.92	4.13	2.4e-05	0.00012	8.41	2.51	44.1
R-HSA-5696394	DNA Damage Recognition in GG-NER	38	30	1.73	4.15	2.6e-05	0.00013	4.51	2.02	11.4
R-HSA-1430728	Metabolism	1899	944	1.09	4.07	2.7e-05	0.00013	1.23	1.11	1.36
R-HSA-5689880	Ub-specific processing proteases	220	130	1.3	4.09	3e-05	0.00015	1.75	1.32	2.32
R-HSA-5628897	TP53 Regulates Metabolic Genes	86	58	1.48	4.1	3.2e-05	0.00016	2.5	1.56	4.08
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	165	101	1.34	4.08	3.2e-05	0.00016	1.91	1.38	2.66
R-HSA-5655862	Translesion synthesis by POLK	17	16	2.07	4.03	3.3e-05	0.00016	19.2	2.98	803
R-HSA-5656121	Translesion synthesis by POLI	17	16	2.07	4.03	3.3e-05	0.00016	19.2	2.98	803
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	32	26	1.78	4.06	3.6e-05	0.00018	5.21	2.09	15.5
R-HSA-5619084	ABC transporter disorders	81	55	1.49	4.06	3.7e-05	0.00018	2.55	1.57	4.24
R-HSA-186763	Downstream signal transduction	29	24	1.82	4.03	4.2e-05	2e-04	5.77	2.16	19.4
R-HSA-15869	Metabolism of nucleotides	101	66	1.44	4.02	4.3e-05	0.00021	2.28	1.48	3.54
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	37	29	1.72	4.02	4.5e-05	0.00022	4.36	1.94	11
R-HSA-6803529	FGFR2 alternative splicing	26	22	1.86	4.01	4.5e-05	0.00022	6.61	2.24	26.4
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	47	35	1.64	3.99	5.1e-05	0.00025	3.51	1.78	7.44
R-HSA-73893	DNA Damage Bypass	49	36	1.61	3.94	6.5e-05	0.00031	3.33	1.72	6.86
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	44	33	1.65	3.94	6.6e-05	0.00032	3.61	1.78	7.92
R-HSA-112382	Formation of RNA Pol II elongation complex 	61	43	1.55	3.93	6.7e-05	0.00032	2.88	1.62	5.31
R-HSA-75955	RNA Polymerase II Transcription Elongation	61	43	1.55	3.93	6.7e-05	0.00032	2.88	1.62	5.31
R-HSA-168254	Influenza Infection	154	94	1.34	3.9	6.9e-05	0.00032	1.89	1.35	2.67
R-HSA-110312	Translesion synthesis by REV1	16	15	2.06	3.88	6.8e-05	0.00032	18	2.77	756
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	16	15	2.06	3.88	6.8e-05	0.00032	18	2.77	756
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	16	15	2.06	3.88	6.8e-05	0.00032	18	2.77	756
R-HSA-195258	RHO GTPase Effectors	313	176	1.24	3.87	7.3e-05	0.00034	1.56	1.24	1.97
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	28	23	1.8	3.9	7.6e-05	0.00035	5.53	2.05	18.6
R-HSA-168255	Influenza Life Cycle	143	88	1.35	3.87	7.7e-05	0.00035	1.93	1.36	2.77
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	25	21	1.85	3.87	8.5e-05	0.00039	6.31	2.13	25.3
R-HSA-191273	Cholesterol biosynthesis	25	21	1.85	3.87	8.5e-05	0.00039	6.31	2.13	25.3
R-HSA-429947	Deadenylation of mRNA	25	21	1.85	3.87	8.5e-05	0.00039	6.31	2.13	25.3
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	25	21	1.85	3.87	8.5e-05	0.00039	6.31	2.13	25.3
R-HSA-166520	Signalling by NGF	147	90	1.34	3.85	8.4e-05	0.00039	1.91	1.35	2.71
R-HSA-2559585	Oncogene Induced Senescence	33	26	1.73	3.84	9.7e-05	0.00044	4.46	1.89	12.2
R-HSA-8856828	Clathrin-mediated endocytosis	140	86	1.35	3.81	1e-04	0.00045	1.92	1.35	2.76
R-HSA-73772	RNA Polymerase I Promoter Escape	30	24	1.76	3.8	0.00012	0.00053	4.81	1.91	14.4
R-HSA-202424	Downstream TCR signaling	98	63	1.41	3.75	0.00013	0.00059	2.17	1.41	3.39
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	27	22	1.79	3.76	0.00014	0.00062	5.29	1.95	17.9
R-HSA-5358508	Mismatch Repair	15	14	2.05	3.72	0.00014	0.00062	16.8	2.55	708
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	100	64	1.41	3.73	0.00014	0.00063	2.14	1.4	3.33
R-HSA-6807878	COPI-mediated anterograde transport	102	65	1.4	3.71	0.00015	0.00067	2.12	1.39	3.27
R-HSA-381070	IRE1alpha activates chaperones	59	41	1.53	3.71	0.00016	0.00072	2.74	1.54	5.08
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	42	31	1.62	3.69	0.00018	8e-04	3.39	1.66	7.48
R-HSA-8852135	Protein ubiquitination	77	51	1.46	3.66	0.00019	0.00083	2.36	1.44	3.95
R-HSA-72086	mRNA Capping	29	23	1.74	3.66	0.00021	0.00091	4.61	1.82	13.8
R-HSA-3247509	Chromatin modifying enzymes	227	130	1.26	3.6	0.00022	0.00093	1.62	1.23	2.14
R-HSA-4839726	Chromatin organization	227	130	1.26	3.6	0.00022	0.00093	1.62	1.23	2.14
R-HSA-2559583	Cellular Senescence	194	113	1.28	3.59	0.00022	0.00095	1.69	1.25	2.28
R-HSA-202403	TCR signaling	116	72	1.36	3.6	0.00023	0.00099	1.97	1.33	2.95
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	39	29	1.63	3.62	0.00024	0.001	3.49	1.65	8.03
R-HSA-901042	Calnexin/calreticulin cycle	26	21	1.77	3.61	0.00025	0.0011	5.04	1.85	17.1
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	23	19	1.81	3.58	0.00029	0.0012	5.7	1.89	23.1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	23	19	1.81	3.58	0.00029	0.0012	5.7	1.89	23.1
R-HSA-162594	Early Phase of HIV Life Cycle	14	13	2.04	3.56	0.00029	0.0012	15.6	2.34	661
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	14	13	2.04	3.56	0.00029	0.0012	15.6	2.34	661
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	14	13	2.04	3.56	0.00029	0.0012	15.6	2.34	661
R-HSA-68884	Mitotic Telophase/Cytokinesis	14	13	2.04	3.56	0.00029	0.0012	15.6	2.34	661
R-HSA-6804757	Regulation of TP53 Degradation	36	27	1.65	3.56	0.00031	0.0013	3.61	1.64	8.72
R-HSA-1268020	Mitochondrial protein import	20	17	1.87	3.55	0.00032	0.0013	6.8	1.97	36.2
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	20	17	1.87	3.55	0.00032	0.0013	6.8	1.97	36.2
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	20	17	1.87	3.55	0.00032	0.0013	6.8	1.97	36.2
R-HSA-69186	Lagging Strand Synthesis	20	17	1.87	3.55	0.00032	0.0013	6.8	1.97	36.2
R-HSA-382556	ABC-family proteins mediated transport	104	65	1.37	3.5	0.00034	0.0014	2.01	1.33	3.08
R-HSA-68875	Mitotic Prophase	134	81	1.33	3.49	0.00034	0.0014	1.84	1.29	2.66
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	28	22	1.73	3.52	0.00037	0.0015	4.4	1.73	13.3
R-HSA-9006936	Signaling by TGF-beta family members	95	60	1.39	3.47	0.00038	0.0015	2.07	1.34	3.24
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	10	10	2.2	3.46	0.00038	0.0015	Inf	2.69	Inf
R-HSA-9007101	Rab regulation of trafficking	123	75	1.34	3.46	0.00038	0.0015	1.88	1.29	2.77
R-HSA-381038	XBP1(S) activates chaperone genes	57	39	1.5	3.48	0.00039	0.0016	2.61	1.45	4.85
R-HSA-5693538	Homology Directed Repair	137	82	1.31	3.39	0.00048	0.0019	1.8	1.26	2.59
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	30	23	1.68	3.43	0.00051	0.002	3.95	1.64	10.9
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	23	1.68	3.43	0.00051	0.002	3.95	1.64	10.9
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	120	73	1.34	3.39	5e-04	0.002	1.87	1.28	2.77
R-HSA-187687	Signalling to ERKs	22	18	1.8	3.42	0.00054	0.0021	5.4	1.78	22
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	47	33	1.54	3.41	0.00053	0.0021	2.83	1.47	5.74
R-HSA-5620924	Intraflagellar transport	54	37	1.51	3.4	0.00053	0.0021	2.62	1.44	4.96
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	72	47	1.43	3.38	0.00055	0.0022	2.26	1.36	3.84
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	19	16	1.85	3.39	0.00061	0.0023	6.4	1.83	34.3
R-HSA-176412	Phosphorylation of the APC/C	19	16	1.85	3.39	0.00061	0.0023	6.4	1.83	34.3
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	13	12	2.03	3.39	0.00059	0.0023	14.4	2.13	614
R-HSA-2995410	Nuclear Envelope Reassembly	13	12	2.03	3.39	0.00059	0.0023	14.4	2.13	614
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	13	12	2.03	3.39	0.00059	0.0023	14.4	2.13	614
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	42	30	1.57	3.38	6e-04	0.0023	3	1.49	6.45
R-HSA-432722	Golgi Associated Vesicle Biogenesis	56	38	1.49	3.37	6e-04	0.0023	2.54	1.41	4.73
R-HSA-156711	Polo-like kinase mediated events	16	14	1.92	3.37	0.00065	0.0025	8.4	1.93	76.1
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	27	21	1.71	3.37	0.00065	0.0025	4.2	1.64	12.7
R-HSA-6806003	Regulation of TP53 Expression and Degradation	37	27	1.6	3.36	0.00065	0.0025	3.24	1.52	7.52
R-HSA-5656169	Termination of translesion DNA synthesis	32	24	1.65	3.35	0.00067	0.0025	3.6	1.56	9.29
R-HSA-446652	Interleukin-1 family signaling	138	82	1.31	3.3	0.00066	0.0025	1.77	1.24	2.53
R-HSA-450294	MAP kinase activation in TLR cascade	60	40	1.46	3.3	0.00075	0.0028	2.41	1.37	4.35
R-HSA-203927	MicroRNA (miRNA) biogenesis	24	19	1.74	3.31	8e-04	0.003	4.56	1.65	15.6
R-HSA-539107	Activation of E2F1 target genes at G1/S	24	19	1.74	3.31	8e-04	0.003	4.56	1.65	15.6
R-HSA-69205	G1/S-Specific Transcription	24	19	1.74	3.31	8e-04	0.003	4.56	1.65	15.6
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	39	28	1.58	3.3	0.00079	0.003	3.06	1.47	6.82
R-HSA-168273	Influenza Viral RNA Transcription and Replication	133	79	1.3	3.24	0.00084	0.0031	1.76	1.23	2.55
R-HSA-351202	Metabolism of polyamines	84	53	1.39	3.25	0.00085	0.0032	2.06	1.29	3.32
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	21	17	1.78	3.26	0.00098	0.0036	5.1	1.66	20.8
R-HSA-73886	Chromosome Maintenance	109	66	1.33	3.17	0.0011	0.004	1.85	1.24	2.79
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	31	23	1.63	3.21	0.0011	0.0041	3.45	1.49	8.94
R-HSA-73863	RNA Polymerase I Transcription Termination	31	23	1.63	3.21	0.0011	0.0041	3.45	1.49	8.94
R-HSA-3371511	HSF1 activation	12	11	2.01	3.21	0.0012	0.0044	13.2	1.92	567
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	15	13	1.9	3.2	0.0013	0.0044	7.8	1.76	71.4
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	15	13	1.9	3.2	0.0013	0.0044	7.8	1.76	71.4
R-HSA-5099900	WNT5A-dependent internalization of FZD4	15	13	1.9	3.2	0.0013	0.0044	7.8	1.76	71.4
R-HSA-69298	Association of licensing factors with the pre-replicative complex	15	13	1.9	3.2	0.0013	0.0044	7.8	1.76	71.4
R-HSA-8956320	Nucleobase biosynthesis	15	13	1.9	3.2	0.0013	0.0044	7.8	1.76	71.4
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	52	35	1.48	3.16	0.0012	0.0044	2.48	1.35	4.72
R-HSA-199992	trans-Golgi Network Vesicle Budding	72	46	1.4	3.14	0.0013	0.0044	2.13	1.29	3.59
R-HSA-421837	Clathrin derived vesicle budding	72	46	1.4	3.14	0.0013	0.0044	2.13	1.29	3.59
R-HSA-1989781	PPARA activates gene expression	117	70	1.31	3.13	0.0012	0.0044	1.79	1.22	2.66
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	38	27	1.56	3.17	0.0013	0.0045	2.95	1.41	6.59
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	100	61	1.34	3.12	0.0013	0.0045	1.88	1.24	2.9
R-HSA-167169	HIV Transcription Elongation	23	18	1.72	3.16	0.0014	0.0049	4.32	1.54	14.9
R-HSA-167172	Transcription of the HIV genome	23	18	1.72	3.16	0.0014	0.0049	4.32	1.54	14.9
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	23	18	1.72	3.16	0.0014	0.0049	4.32	1.54	14.9
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	23	18	1.72	3.16	0.0014	0.0049	4.32	1.54	14.9
R-HSA-6802957	Oncogenic MAPK signaling	76	48	1.39	3.1	0.0014	0.005	2.06	1.27	3.42
R-HSA-381042	PERK regulates gene expression	28	21	1.65	3.14	0.0015	0.0051	3.6	1.47	10
R-HSA-6783310	Fanconi Anemia Pathway	40	28	1.54	3.11	0.0015	0.0052	2.8	1.38	6.06
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	97	59	1.34	3.04	0.0017	0.0057	1.87	1.22	2.89
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	42	29	1.52	3.07	0.0017	0.006	2.68	1.35	5.62
R-HSA-2132295	MHC class II antigen presentation	124	73	1.29	3	0.0018	0.0062	1.72	1.19	2.52
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	51	34	1.46	3.04	0.0018	0.0063	2.4	1.3	4.59
R-HSA-182971	EGFR downregulation	25	19	1.67	3.06	0.0019	0.0065	3.8	1.46	11.6
R-HSA-5654738	Signaling by FGFR2	73	46	1.38	3.01	0.0019	0.0065	2.05	1.25	3.43
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	90	55	1.34	2.98	0.002	0.0069	1.89	1.21	2.98
R-HSA-6806834	Signaling by MET	79	49	1.36	2.96	0.0022	0.0076	1.96	1.22	3.21
R-HSA-166166	MyD88-independent TLR4 cascade 	98	59	1.32	2.93	0.0023	0.0079	1.82	1.19	2.81
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	98	59	1.32	2.93	0.0023	0.0079	1.82	1.19	2.81
R-HSA-174414	Processive synthesis on the C-strand of the telomere	11	10	2	3.02	0.0025	0.0081	12	1.7	519
R-HSA-379726	Mitochondrial tRNA aminoacylation	14	12	1.88	3.02	0.0024	0.0081	7.2	1.6	66.3
R-HSA-6790901	rRNA modification in the nucleus and cytosol	11	10	2	3.02	0.0025	0.0081	12	1.7	519
R-HSA-68689	CDC6 association with the ORC:origin complex	11	10	2	3.02	0.0025	0.0081	12	1.7	519
R-HSA-8934903	Receptor Mediated Mitophagy	11	10	2	3.02	0.0025	0.0081	12	1.7	519
R-HSA-1592230	Mitochondrial biogenesis	68	43	1.39	2.94	0.0024	0.0081	2.07	1.23	3.54
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	102	61	1.31	2.91	0.0025	0.0082	1.79	1.18	2.74
R-HSA-5683057	MAPK family signaling cascades	288	155	1.18	2.87	0.0025	0.0083	1.41	1.11	1.8
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	131	76	1.27	2.89	0.0026	0.0085	1.66	1.16	2.41
R-HSA-1433557	Signaling by SCF-KIT	41	28	1.5	2.93	0.0027	0.0088	2.59	1.3	5.45
R-HSA-1483257	Phospholipid metabolism	200	111	1.22	2.86	0.0027	0.0088	1.5	1.12	2.02
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	61	39	1.4	2.9	0.0028	0.0092	2.13	1.23	3.78
R-HSA-5205647	Mitophagy	29	21	1.59	2.91	0.0031	0.0099	3.15	1.34	8.24
R-HSA-1280218	Adaptive Immune System	746	376	1.11	2.78	0.0031	0.0099	1.24	1.06	1.44
R-HSA-110320	Translesion Synthesis by POLH	19	15	1.73	2.93	0.0031	0.01	4.5	1.43	18.6
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	19	15	1.73	2.93	0.0031	0.01	4.5	1.43	18.6
R-HSA-1643713	Signaling by EGFR in Cancer	19	15	1.73	2.93	0.0031	0.01	4.5	1.43	18.6
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	19	15	1.73	2.93	0.0031	0.01	4.5	1.43	18.6
R-HSA-400253	Circadian Clock	36	25	1.53	2.89	0.0032	0.01	2.73	1.29	6.15
R-HSA-5673001	RAF/MAP kinase cascade	243	132	1.19	2.79	0.0033	0.01	1.44	1.1	1.87
R-HSA-71291	Metabolism of amino acids and derivatives	251	136	1.19	2.79	0.0033	0.01	1.43	1.1	1.85
R-HSA-194840	Rho GTPase cycle	138	79	1.26	2.79	0.0035	0.011	1.61	1.13	2.31
R-HSA-5621481	C-type lectin receptors (CLRs)	138	79	1.26	2.79	0.0035	0.011	1.61	1.13	2.31
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	16	13	1.78	2.87	0.0039	0.012	5.2	1.43	28.4
R-HSA-8949664	Processing of SMDT1	16	13	1.78	2.87	0.0039	0.012	5.2	1.43	28.4
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	26	19	1.61	2.83	0.0041	0.013	3.26	1.31	9.18
R-HSA-6807004	Negative regulation of MET activity	21	16	1.67	2.83	0.0043	0.013	3.84	1.34	13.4
R-HSA-901032	ER Quality Control Compartment (ERQC)	21	16	1.67	2.83	0.0043	0.013	3.84	1.34	13.4
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	96	57	1.3	2.74	0.0043	0.013	1.76	1.15	2.72
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	13	11	1.86	2.83	0.0046	0.014	6.59	1.44	61.3
R-HSA-167044	Signalling to RAS	13	11	1.86	2.83	0.0046	0.014	6.59	1.44	61.3
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-2470946	Cohesin Loading onto Chromatin	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-74749	Signal attenuation	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	10	9	1.98	2.83	0.0049	0.015	10.8	1.49	472
R-HSA-6802949	Signaling by RAS mutants	53	34	1.41	2.73	0.0048	0.015	2.15	1.19	4
R-HSA-6811438	Intra-Golgi traffic	44	29	1.45	2.72	0.0051	0.015	2.32	1.2	4.67
R-HSA-448424	Interleukin-17 signaling	68	42	1.36	2.7	0.005	0.015	1.94	1.16	3.3
R-HSA-190236	Signaling by FGFR	87	52	1.31	2.68	0.0051	0.015	1.79	1.14	2.83
R-HSA-5684996	MAPK1/MAPK3 signaling	249	134	1.18	2.66	0.0048	0.015	1.41	1.08	1.83
R-HSA-166208	mTORC1-mediated signalling	23	17	1.62	2.74	0.0055	0.016	3.4	1.28	10.5
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	23	17	1.62	2.74	0.0055	0.016	3.4	1.28	10.5
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	23	17	1.62	2.74	0.0055	0.016	3.4	1.28	10.5
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	46	30	1.43	2.69	0.0055	0.017	2.25	1.19	4.43
R-HSA-73857	RNA Polymerase II Transcription	1230	602	1.08	2.57	0.0055	0.017	1.17	1.04	1.32
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	82	49	1.31	2.6	0.0065	0.019	1.79	1.12	2.87
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	82	49	1.31	2.6	0.0065	0.019	1.79	1.12	2.87
R-HSA-975871	MyD88 cascade initiated on plasma membrane	82	49	1.31	2.6	0.0065	0.019	1.79	1.12	2.87
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5637810	Constitutive Signaling by EGFRvIII	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-5637812	Signaling by EGFRvIII in Cancer	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-69183	Processive synthesis on the lagging strand	15	12	1.76	2.68	0.0071	0.02	4.8	1.29	26.5
R-HSA-380994	ATF4 activates genes	25	18	1.58	2.66	0.0067	0.02	3.09	1.23	8.75
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	32	22	1.51	2.64	0.0067	0.02	2.64	1.2	6.25
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	20	15	1.65	2.65	0.0073	0.021	3.6	1.24	12.7
R-HSA-354192	Integrin alphaIIb beta3 signaling	27	19	1.55	2.6	0.008	0.023	2.85	1.19	7.53
R-HSA-9006921	Integrin signaling	27	19	1.55	2.6	0.008	0.023	2.85	1.19	7.53
R-HSA-186797	Signaling by PDGF	58	36	1.36	2.54	0.0081	0.023	1.97	1.12	3.51
R-HSA-6802952	Signaling by BRAF and RAF fusions	60	37	1.35	2.52	0.0085	0.024	1.93	1.12	3.41
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	12	10	1.83	2.63	0.0087	0.025	5.99	1.28	56.2
R-HSA-8866427	VLDLR internalisation and degradation	12	10	1.83	2.63	0.0087	0.025	5.99	1.28	56.2
R-HSA-8876384	Listeria monocytogenes entry into host cells	12	10	1.83	2.63	0.0087	0.025	5.99	1.28	56.2
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	22	16	1.6	2.57	0.0091	0.026	3.2	1.19	9.99
R-HSA-1227986	Signaling by ERBB2	49	31	1.39	2.5	0.0093	0.026	2.07	1.12	3.93
R-HSA-3781860	Diseases associated with N-glycosylation of proteins	17	13	1.68	2.56	0.0096	0.027	3.9	1.2	16.4
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	17	13	1.68	2.56	0.0096	0.027	3.9	1.2	16.4
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	17	13	1.68	2.56	0.0096	0.027	3.9	1.2	16.4
R-HSA-8949215	Mitochondrial calcium ion transport	17	13	1.68	2.56	0.0096	0.027	3.9	1.2	16.4
R-HSA-75153	Apoptotic execution  phase	51	32	1.38	2.48	0.0098	0.027	2.02	1.11	3.78
R-HSA-5674135	MAP2K and MAPK activation	40	26	1.43	2.48	0.01	0.028	2.23	1.12	4.62
R-HSA-4420097	VEGFA-VEGFR2 Pathway	95	55	1.27	2.43	0.01	0.028	1.65	1.08	2.56
R-HSA-6799198	Complex I biogenesis	55	34	1.36	2.43	0.011	0.03	1.94	1.09	3.53
R-HSA-5357801	Programmed Cell Death	115	65	1.24	2.38	0.011	0.031	1.56	1.06	2.31
R-HSA-5619115	Disorders of transmembrane transporters	149	82	1.21	2.35	0.012	0.033	1.47	1.05	2.07
R-HSA-1433559	Regulation of KIT signaling	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-174411	Polymerase switching on the C-strand of the telomere	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-69091	Polymerase switching	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-69109	Leading Strand Synthesis	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-69166	Removal of the Flap Intermediate	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	14	11	1.73	2.48	0.013	0.034	4.4	1.16	24.6
R-HSA-180024	DARPP-32 events	19	14	1.62	2.47	0.012	0.034	3.36	1.14	11.9
R-HSA-8876725	Protein methylation	19	14	1.62	2.47	0.012	0.034	3.36	1.14	11.9
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	35	23	1.44	2.4	0.013	0.034	2.3	1.1	5.08
R-HSA-1236975	Antigen processing-Cross presentation	88	51	1.27	2.35	0.013	0.034	1.66	1.06	2.61
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	90	52	1.27	2.35	0.013	0.034	1.64	1.06	2.57
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	92	53	1.27	2.34	0.013	0.034	1.63	1.06	2.54
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	92	53	1.27	2.34	0.013	0.034	1.63	1.06	2.54
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	92	53	1.27	2.34	0.013	0.034	1.63	1.06	2.54
R-HSA-975155	MyD88 dependent cascade initiated on endosome	92	53	1.27	2.34	0.013	0.034	1.63	1.06	2.54
R-HSA-71387	Metabolism of carbohydrates	263	138	1.15	2.29	0.013	0.034	1.33	1.03	1.72
R-HSA-109581	Apoptosis	108	61	1.24	2.3	0.014	0.037	1.56	1.05	2.34
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	118	66	1.23	2.28	0.014	0.038	1.53	1.04	2.24
R-HSA-5620916	VxPx cargo-targeting to cilium	21	15	1.57	2.39	0.015	0.039	3	1.1	9.44
R-HSA-177504	Retrograde neurotrophin signalling	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-189451	Heme biosynthesis	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-4641265	Repression of WNT target genes	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-5655291	Signaling by FGFR4 in disease	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-8851805	MET activates RAS signaling	11	9	1.8	2.42	0.016	0.042	5.39	1.12	51.3
R-HSA-917937	Iron uptake and transport	58	35	1.33	2.27	0.016	0.042	1.83	1.05	3.24
R-HSA-70895	Branched-chain amino acid catabolism	23	16	1.53	2.32	0.017	0.044	2.74	1.07	7.89
R-HSA-194138	Signaling by VEGF	103	58	1.24	2.21	0.018	0.045	1.55	1.03	2.35
R-HSA-556833	Metabolism of lipids	696	344	1.09	2.14	0.018	0.045	1.18	1.01	1.38
R-HSA-5693537	Resolution of D-Loop Structures	34	22	1.42	2.25	0.019	0.048	2.2	1.04	4.88
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	25	17	1.49	2.26	0.02	0.05	2.55	1.04	6.83
